Article: Ranbaxy Laboratories registers 20 percent net profit gain in first half ended September 30.

New Delhi, India--(BUSINESS WIRE)--October 27, 1995--Ranbaxy Laboratories, Ltd (GDR:RBXD - London) announced half-year unaudited results for the six months ended September 30, 1995.

Sales at Rs. 4152.5 million registered 21 percent growth over the prior year's comparable period. Profit before tax at Rs. 691.0 million increased by 25 percent and profit after tax at Rs. 595.0 increased 20 percent over last year.

The company said that exports during the period of Rs. 1737 million reflect an increase of 32 percent over the comparable period last year and represent 42 percent of total turnover.

Chairman and Managing Director Dr. Parvinder Singh said that ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!